CYP450 genotype and pharmacogenetic association studies: a critical appraisal
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CYP450 genotype and pharmacogenetic association studies: a critical appraisal
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 17, Issue 3, Pages 259-275
Publisher
Future Medicine Ltd
Online
2016-01-19
DOI
10.2217/pgs.15.172
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of visceral leishmaniasis and curative chemotherapy on cytochrome P450 activity in Brazilian patients
- (2015) Vera Lucia Lanchote et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- In vivoassessment of the metabolic activity of CYP2D6 diplotypes and alleles
- (2015) Daniel L. Hertz et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Opposite malaria and pregnancy effect on oral bioavailability of artesunate - a population pharmacokinetic evaluation
- (2015) Frank Kloprogge et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Addressing phenoconversion: the Achilles' heel of personalized medicine
- (2015) Rashmi R. Shah et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Individualization of tamoxifen therapy: Much more than just CYP2D6 genotyping
- (2015) Lisette Binkhorst et al. CANCER TREATMENT REVIEWS
- Lower CYP2C9 activity in Turkish patients with Behçet’s disease compared to healthy subjects: a down-regulation due to inflammation?
- (2015) Mustafa Tugrul Goktaş et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Phenoconversion of CYP2C9 in epilepsy limits the predictive value of CYP2C9 genotype in optimizing valproate therapy
- (2015) Katalin Tóth et al. Personalized Medicine
- Poor warfarin dose prediction with pharmacogenetic algorithms that exclude genotypes important for African Americans
- (2015) Katarzyna Drozda et al. Pharmacogenetics and Genomics
- CYP3A4*22is related to increased plasma levels of 4-hydroxytamoxifen and partially compensates for reduced CYP2D6 activation of tamoxifen
- (2015) Marina Venzon Antunes et al. PHARMACOGENOMICS
- The Effect of Tamoxifen Dose Increment in Patients With Impaired CYP2D6 Activity
- (2015) Marieke E. B. Welzen et al. THERAPEUTIC DRUG MONITORING
- Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study
- (2015) R. J. Desai et al. BMJ-British Medical Journal
- Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study
- (2015) R. J. Desai et al. BMJ-British Medical Journal
- CYP2C9 Genotype vs. Metabolic Phenotype for Individual Drug Dosing—A Correlation Analysis Using Flurbiprofen as Probe Drug
- (2015) Silvia Vogl et al. PLoS One
- Patterns of Opioid Utilization in Pregnancy in a Large Cohort of Commercial Insurance Beneficiaries in the United States
- (2014) Brian T. Bateman et al. ANESTHESIOLOGY
- Inflammation Is Associated with Voriconazole Trough Concentrations
- (2014) Marjolijn J. P. van Wanrooy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- CYP2C19 genotype–phenotype discordance in patients with multiple myeloma leads to an acquired loss of drug-metabolising activity
- (2014) K. E. Burns et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Challenges in CYP2D6 Phenotype Assignment from Genotype Data: A Critical Assessment and Call for Standardization
- (2014) J. Hicks et al. CURRENT DRUG METABOLISM
- Functional Characterization of Wild-type and 49 CYP2D6 Allelic Variants for N-Desmethyltamoxifen 4-Hydroxylation Activity
- (2014) Yuka Muroi et al. Drug Metabolism and Pharmacokinetics
- Interethnic variability ofCYP2D6alleles and of predicted and measured metabolic phenotypes across world populations
- (2014) Adrián LLerena et al. Expert Opinion on Drug Metabolism & Toxicology
- A systematic review and critical assessment of 11 discordant meta-analyses on reduced-function CYP2C19 genotype and risk of adverse clinical outcomes in clopidogrel users
- (2014) Ruben L. Osnabrugge et al. GENETICS IN MEDICINE
- Response to CYP2D6 substrate antidepressants is predicted by a CYP2D6 composite phenotype based on genotype and comedications with CYP2D6 inhibitors
- (2014) F. Gressier et al. JOURNAL OF NEURAL TRANSMISSION
- Relationship between the CYP2C9 IVS8-109A>T polymorphism and high losartan hydroxylation in healthy Ecuadorian volunteers
- (2014) Pedro Dorado et al. PHARMACOGENOMICS
- Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer
- (2014) P Saladores et al. PHARMACOGENOMICS JOURNAL
- Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice
- (2013) Kathryn J. Ruddy et al. BREAST CANCER RESEARCH AND TREATMENT
- CYP2D6 Genotype and Adjuvant Tamoxifen: Meta-Analysis of Heterogeneous Study Populations
- (2013) M A Province et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetics, Epigenetics, and Regulation of Drug-Metabolizing Cytochrome P450 Enzymes
- (2013) U M Zanger et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cytochrome P450 pharmacogenetics in African populations
- (2013) Marco Alessandrini et al. DRUG METABOLISM REVIEWS
- Interaction of Terbinafine (Anti-fungal agent) with Perhexiline: A Case Report
- (2013) Abdul Rauf Sheikh et al. Heart Lung and Circulation
- The impact of interacting drugs on dispensed doses of warfarin in the Swedish population: A novel use of population based drug registers
- (2013) M.L. Andersson et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Cytochrome P450 2D6 Phenoconversion Is Common in Patients Being Treated for Depression
- (2013) Sheldon H. Preskorn et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Randomized Trial of Genotype-Guided Dosing of Acenocoumarol and Phenprocoumon
- (2013) Talitha I. Verhoef et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing
- (2013) Stephen E. Kimmel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial of Genotype-Guided Dosing of Warfarin
- (2013) Munir Pirmohamed et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of HNF4α genetic polymorphism G60D on the pharmacokinetics of CYP2D6 substrate tolterodine in healthy Korean individuals
- (2013) Fen Jiang et al. Pharmacogenetics and Genomics
- Characterization of the CYP2D6 gene locus and metabolic activity in Indo- and Afro-Trinidadians: discovery of novel allelic variants
- (2013) Lazara Karelia Montané Jaime et al. PHARMACOGENOMICS
- Pregnancy and pharmacogenomics in the context of drug metabolism and response
- (2013) Anders Helldén et al. PHARMACOGENOMICS
- Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
- (2013) Ulrich M. Zanger et al. PHARMACOLOGY & THERAPEUTICS
- CYP2D6 Genotype and Tamoxifen Response for Breast Cancer: A Systematic Review and Meta-Analysis
- (2013) Danny W. K. Lum et al. PLoS One
- Functional Polymorphisms in Xenobiotic Metabolizing Enzymes and Their Impact on the Therapy of Breast Cancer
- (2013) Rosane Vianna-Jorge et al. Frontiers in Genetics
- The use of the 13C-dextromethorphan breath test for phenotyping CYP2D6 in breast cancer patients using tamoxifen: association with CYP2D6 genotype and serum endoxifen levels
- (2012) F. L. Opdam et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Electronic Medical Records as a Tool in Clinical Pharmacology: Opportunities and Challenges
- (2012) D M Roden et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Search for the molecular basis of ultra-rapid CYP2C9-catalysed metabolism: relationship between SNP IVS8-109A>T and the losartan metabolism phenotype in Swedes
- (2012) Fazleen H. M. Hatta et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- CYP2D6 Genotype Information to Guide Pimozide Treatment in Adult and Pediatric Patients
- (2012) Hobart L. Rogers et al. JOURNAL OF CLINICAL PSYCHIATRY
- Resection of the epileptogenic lesion abolishes seizures and reduces inflammatory cytokines of patients with temporal lobe epilepsy
- (2012) Thereza Quirico-Santos et al. JOURNAL OF NEUROIMMUNOLOGY
- CYP2D6 and UGT2B7 Genotype and Risk of Recurrence in Tamoxifen-Treated Breast Cancer Patients
- (2012) James M. Rae et al. JNCI-Journal of the National Cancer Institute
- Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection
- (2012) F. Girardin et al. JOURNAL OF VIRAL HEPATITIS
- Tamoxifen and CYP2D6: A Contradiction of Data
- (2012) D. L. Hertz et al. ONCOLOGIST
- Immunological Response as a Source to Variability in Drug Metabolism and Transport
- (2012) Hege Christensen et al. Frontiers in Pharmacology
- Activity Levels of Tamoxifen Metabolites at the Estrogen Receptor and the Impact of Genetic Polymorphisms of Phase I and II Enzymes on Their Concentration Levels in Plasma
- (2011) T E Mürdter et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Dextromethorphan As a Phenotyping Test to Predict Endoxifen Exposure in Patients on Tamoxifen Treatment
- (2011) Anne-Joy M. de Graan et al. JOURNAL OF CLINICAL ONCOLOGY
- Genotype-Guided Tamoxifen Dosing Increases Active Metabolite Exposure in Women With Reduced CYP2D6 Metabolism: A Multicenter Study
- (2011) William J. Irvin et al. JOURNAL OF CLINICAL ONCOLOGY
- Cytokines and epilepsy
- (2011) Gang Li et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Variability in drug metabolizing enzyme activity in HIV-infected patients
- (2010) Amanda E. Jones et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy
- (2010) Guillermo Gervasini et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Composite Functional Genetic and Comedication CYP2D6 Activity Score in Predicting Tamoxifen Drug Exposure Among Breast Cancer Patients
- (2010) Silvana Borges et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance
- (2009) Shu-Feng Zhou CLINICAL PHARMACOKINETICS
- Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance
- (2009) Shu-Feng Zhou CLINICAL PHARMACOKINETICS
- Multi-centre experience on the use of perhexiline in chronic heart failure and refractory angina: old drug, new hope
- (2009) Thanh Trung Phan et al. EUROPEAN JOURNAL OF HEART FAILURE
- Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen
- (2009) Werner Schroth JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cellular injury and neuroinflammation in children with chronic intractable epilepsy
- (2009) Jieun Choi et al. Journal of Neuroinflammation
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Can extremely low or high morphine formation from codeine be predicted prior to therapy initiation?
- (2009) Jörn Lötsch et al. PAIN
- CYP2C9*8is prevalent among African–Americans: implications for pharmacogenetic dosing
- (2009) Stuart A Scott et al. PHARMACOGENOMICS
- CYP2C19 pharmacogenetics in advanced cancer: compromised function independent of genotype
- (2008) N A Helsby et al. BRITISH JOURNAL OF CANCER
- CYP2D6 Phenotype Prediction From Genotype: Which System Is the Best?
- (2008) J Kirchheiner CLINICAL PHARMACOLOGY & THERAPEUTICS
- Regulation of Hepatocyte Nuclear Factor 4α-mediated Transcription
- (2008) Frank J. Gonzalez Drug Metabolism and Pharmacokinetics
- Genetic polymorphism of hepatocyte nuclear factor-4α influences human cytochrome P450 2D6 activity
- (2008) Sang Seop Lee et al. HEPATOLOGY
- Genetic Determinants of Response to Clopidogrel and Cardiovascular Events
- (2008) Tabassome Simon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Terbinafine-associated inhibition of dextromethorphan metabolism in Chinese subjects
- (2003) W. M. Cai et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started